General Information of the Compound
| Compound ID |
CP0489065
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
3-[1-[1-(4-methoxyphenyl)cyclopropanecarbonyl]piperidin-4-yl]-5-[4-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-one
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C25H24F3N3O4
|
||||||||||||||||||
| Molecular Weight |
487.478
|
||||||||||||||||||
| Canonical SMILES |
COc1ccc(cc1)C1(CC1)C(=O)N1CCC(CC1)n1nc(oc1=O)-c1ccc(cc1)C(F)(F)F
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C25H24F3N3O4/c1-34-20-8-6-17(7-9-20)24(12-13-24)22(32)30-14-10-19(11-15-30)31-23(33)35-21(29-31)16-2-4-18(5-3-16)25(26,27)28/h2-9,19H,10-15H2,1H3
Show/Hide
|
||||||||||||||||||
| InChIKey |
ILQMFSSXZWSVGQ-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound